Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
about
Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease miceMouse models of polyglutamine diseases: review and data table. Part IMutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 miceIntravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington diseaseAttenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's diseaseEarly retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy.Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protectionHypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice.Selective neuronal requirement for huntingtin in the developing zebrafish.The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis.Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway.Fine-structural analysis and connexin expression in the retina of a transgenic model of Huntington's disease.Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease.Enhanced retinal responses in Huntington's disease patients.Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.Imidazolium salt (DBZIM) reduces gliosis in mice treated with neurotoxicant 2'-CH(3) -MPTP.
P2860
Q24795623-C140334D-D70D-4A4C-9866-85C277A02231Q26853025-38141975-6EEA-4BB5-B50D-46E35FD4C33CQ27305680-CD0A57CA-CEBC-4D18-9E92-229C84602109Q28486105-59A4F056-5EBE-4346-9308-F7F80051F7E6Q33640990-4BEBE310-B51D-4426-9737-F8372670E6ABQ34624963-BDA2557F-9546-455A-875A-CC3B1C0DA3BFQ34789382-39A4085D-ECE4-441F-99DB-5F7E8B37C661Q35565116-7C9D9B70-5DA1-4CED-B9CC-E23D272A5093Q35765868-CAF60EFF-BD8F-4BFD-840C-98676105B86CQ36467223-356BF45D-602E-4130-80B1-562C467883BCQ37459887-BED18AE6-E4B4-44E9-ABC3-351F530E47BFQ38235229-547CB2A8-CEFF-4B90-A9C6-E213E6AF5BB6Q40502075-A426ED5F-88D9-495D-95CC-A6F3A9DEA8D1Q42131524-735B4A46-7679-445C-9796-211EBE568363Q42472843-B616D5AC-D6BC-4E37-A6B8-B23304DDFB59Q44323344-D8261751-DE27-40D8-8954-308D98800EACQ45081901-2EB858FA-C93B-4D10-AAB9-3E3B6C8F11F2Q45289374-D80C388F-574A-474D-9934-65FEA6EF9B27Q45293191-60A21EEE-1CEB-4AD6-97CC-A8A0172CDC5FQ46490717-B0122E63-6CF1-443E-8E46-AE665D0C71BCQ47745053-72333542-C2E7-4EF8-A050-F9BACCCCB05AQ48230275-07D3BCDD-C5BA-43C1-9D83-0D720B876444
P2860
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@en
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@nl
type
label
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@en
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@nl
prefLabel
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@en
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@nl
P2093
P50
P356
P1476
Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice.
@en
P2093
Dominique Helmlinger
Gaël Yvert
Jean-Louis Mandel
Karine Merienne
P304
P356
10.1093/HMG/11.26.3351
P577
2002-12-01T00:00:00Z